Background: The World Health Organization (WHO) recommended that the toxicity data of a traditional medicine (TM) product that has been in use for 20 years or more without untoward effects should be determined, as the first step in its research and development (R&D). Such dat...
Open access
Research Article10.9734/BJPR/2014/10617
Sunday J. Ameh, Nneka Ibekwe, Aminu Ambi, Obiageri Obodozie, Mujtaba Abubakar, Magaji Garba, Herbert Cocker & Karniyus S. Gamaniel·European Journal of Medicinal Plants·2014
Background: Herbal drug standardization (HDS) is multidisciplinary with botany and chemistry working together to facilitate decisions on production of herbal medicines. The common reasons for HDS are: i) it creates the need for establishing botanical identity; ii) it is necessary...
Open access
Research Article10.9734/EJMP/2014/5457
Background: Conavir, an immunostimulant from aerial parts of Andrographis paniculata (AP) and Niprd-AM1, an antimalarial from roots of Nauclea latifolia (NL), are dry water extracts for capsulation. AP and NL have been in use in Asia and Africa for centuries. Purpose: The study a...
Open access
Research Article10.9734/BJPR/2013/1887
Sunday J. Ameh, Nneka N. Ibekwe, Aminu A. Ambi, Taoheed Abdulkareem, Barnabas K. Toge, Benjamin U. Ebeshi, John Alfa & Magaji Garba·European Journal of Medicinal Plants·2014
Introduction: An “aroma-active compound” (AAC) has a “flavor”- ie: a “distinct taste and odor”. An example is menthol. All aromatic plants (APs), including some medicinal plants, such as Mentha×piperita (Family Lamiaceae), produce a group of fat-soluble secondary metabolites call...
Open access
Research Article10.9734/EJMP/2014/10779